Results 31 to 40 of about 956 (195)

An elderly with a ‘bony’ smile [PDF]

open access: yesMalaysian Family Physician, 2016
A 62-year-old Caucasian man presented with progressive painless loss of the upper dentition and discolouration of the upper gums. He was referred by a dentist after undergoing dental treatment with debridement twice before his presentation to the ...
Irfan Mohamad , Sanjeevan Nadarajah
doaj  

Oral avascular bone necrosis associated with chemotherapy and biphosphonate therapy

open access: yes, 2015
BACKGROUND: Oral avascular bone necrosis is an important adverse effect of chemotherapy and biphosphate therapy. OBJECTIVE: To report our experience in oral avascular bone necrosis in cancer patients assigned to undergo chemotherapy. PATIENTS AND METHODS:
Pires, FR   +10 more
core   +2 more sources

Long-Term Alendronate Use Not without Consequences? [PDF]

open access: yes, 2009
A previously unknown side effect of biphosphonate use is emerging. In a specific patient group on long term biphosphonate therapy stress femur fractures seem to occur.
Draijer, W. F.   +4 more
core   +1 more source

Biphosphonate-Mediated Gene Vector Delivery from the Metal Surfaces of Stents

open access: yes, 2006
The clinical use of metallic expandable intravascular stents has resulted in imporved therapeutic outcomes for coronary artery disease. However, arterial reobstruction after stenting, in-stent restenosis, remains an important problem.
Wong, Gordon Sek-Yin   +10 more
core   +2 more sources

Intralesion Triamcinolon Injection Therapy on Esophageal Stricture as Side Effect of Long Term Use Biphosphonate

open access: yes, 2018
Systemic Lupus Erythematous (SLE) is a chronic inflammatory disease that affect almost any organ system. Patient with SLE is at risk of osteoporosis. Biphosphonate is one of osteoporosis treatments. However, esophageal stricture (ES) caused by continuous
Arles, Arles, Silvia, Yoanda
core   +2 more sources

Cell Therapy for Periodontal, Soft‐Tissue, and Craniofacial Regeneration

open access: yesJournal of Periodontal Research, EarlyView.
The clinical translation of mesenchymal stem/stromal cells (MSCs) represents a major advancement in dentistry, especially for periodontal, soft‐tissue, and craniofacial regeneration. However, several challenges remain to be addressed, including the absence of standardised protocols, limited scalability, regulatory hurdles, a lack of well‐controlled ...
Kamal Mustafa   +5 more
wiley   +1 more source

Abstracts

open access: yes, 2023
Molecular Oncology, Volume 17, Issue S1, Page 1-597, June 2023.
wiley   +1 more source

Ionic–Bionic Interfaces: Advancing Iontronic Strategies for Bioelectronic Sensing and Therapy

open access: yesAdvanced Science, Volume 13, Issue 16, 18 March 2026.
Ionic–bionic interfaces for bioelectronics leverage ions as multifunctional mediators that combine mechanical compliance, ionic and electronic functionalities, and therapeutic effects. These systems offer real‐time biosignal transduction, effective wound dressing, responsive drug delivery, and seamless interaction between soft tissues and electronic ...
Yun Goo Ro   +6 more
wiley   +1 more source

The Contribution of Cholesterol and Squalene Synthase in Cancer: Molecular Mechanisms, Lipid Rafts and Therapeutic Approaches

open access: yesMedicinal Research Reviews, Volume 46, Issue 2, Page 352-381, March 2026.
ABSTRACT A plethora of cellular signaling pathways are dysregulated in cancer cells, promoting carcinogenesis and migration. Cholesterol has recently been linked to cancer by several subcellular mechanisms, especially by its involvement in the formation of lipid rafts, which promote oncogenic signaling and cancer cell invasion. Squalene synthase (SQS),
Danai Mavridi   +2 more
wiley   +1 more source

The Anti-Osteoporotic Drug Preferences of Physiatrists: A Multicenter Descriptive Study

open access: yesTürk Osteoporoz Dergisi, 2012
Aim: The purpose of this multicenter descriptive study is to determine the preferences of physiatrists in our country for anti-osteoporotic drugs in patients with primary and secondary osteoporosis.
Yeşim Gökçe Kutsal   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy